Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,686 | 515 | 98.5% |
| Education | $119.72 | 4 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,705 | 121 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,131 | 52 | $0 (2024) |
| Merck Sharp & Dohme LLC | $673.68 | 67 | $0 (2024) |
| Lilly USA, LLC | $552.41 | 41 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $519.73 | 38 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $417.49 | 30 | $0 (2023) |
| ABBVIE INC. | $417.35 | 30 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $272.18 | 15 | $0 (2021) |
| Astellas Pharma US Inc | $253.86 | 9 | $0 (2024) |
| GlaxoSmithKline, LLC. | $222.44 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,097 | 50 | Novo Nordisk Inc ($410.15) |
| 2023 | $1,064 | 70 | ABBVIE INC. ($271.99) |
| 2022 | $820.26 | 52 | Novo Nordisk Inc ($231.41) |
| 2021 | $988.19 | 51 | AstraZeneca Pharmaceuticals LP ($269.73) |
| 2020 | $874.80 | 59 | Novo Nordisk Inc ($190.62) |
| 2019 | $1,042 | 84 | Novo Nordisk Inc ($216.09) |
| 2018 | $984.34 | 70 | Novo Nordisk Inc ($154.28) |
| 2017 | $934.61 | 83 | Merck Sharp & Dohme Corporation ($200.76) |
All Payment Transactions
519 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Diabetes | ||||||
| 12/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Endocrinology | ||||||
| 12/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: VACCINE | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: Obesity | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.61 | General |
| Category: Biological | ||||||
| 11/08/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 11/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Biological | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Obesity | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.67 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $28.27 | General |
| Category: Diabetes Care | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.03 | General |
| 09/05/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Biological | ||||||
| 08/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Endocrinology | ||||||
| 07/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Diabetes | ||||||
| 06/27/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $55.06 | General |
| Category: Respiratory | ||||||
| 06/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Obesity | ||||||
| 06/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $27.62 | General |
| Category: Diabetes Care | ||||||
| 06/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 2,928 | 3,914 | $358,655 | $221,453 |
| 2022 | 23 | 2,878 | 4,045 | $301,538 | $168,200 |
| 2021 | 23 | 2,784 | 3,790 | $277,268 | $156,971 |
| 2020 | 23 | 2,485 | 3,292 | $285,026 | $143,191 |
All Medicare Procedures & Services
93 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 161 | 161 | $56,350 | $45,439 | 80.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 357 | 721 | $82,915 | $41,952 | 50.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 285 | 456 | $77,976 | $39,543 | 50.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 260 | 260 | $46,800 | $33,587 | 71.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 195 | 197 | $15,760 | $14,150 | 89.8% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 51 | 51 | $7,650 | $7,293 | 95.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 461 | 788 | $19,700 | $6,619 | 33.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 199 | 201 | $7,839 | $6,060 | 77.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 166 | 166 | $6,474 | $5,005 | 77.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 20 | 22 | $6,731 | $4,860 | 72.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 269 | 269 | $4,839 | $4,853 | 100.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 58 | 61 | $3,660 | $2,433 | 66.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $4,550 | $2,132 | 46.9% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 51 | 51 | $2,820 | $2,038 | 72.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 29 | 36 | $1,534 | $1,163 | 75.8% |
| 0124A | Adm sarscv2 bvl 30mcg/.3ml a | Office | 2023 | 16 | 16 | $960.00 | $643.20 | 67.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 116 | 176 | $2,288 | $600.16 | 26.2% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 19 | 38 | $1,520 | $583.92 | 38.4% |
| G0296 | Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | Office | 2023 | 20 | 20 | $628.60 | $564.20 | 89.8% |
| 82270 | Stool analysis for blood to screen for colon tumors | Office | 2023 | 117 | 117 | $3,159 | $501.93 | 15.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 44 | $1,760 | $497.20 | 28.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 11 | 11 | $770.00 | $496.54 | 64.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 25 | $1,425 | $246.29 | 17.3% |
| 90471 | Administration of vaccine | Office | 2023 | 14 | 14 | $546.00 | $193.80 | 35.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 351 | 706 | $81,190 | $41,874 | 51.6% |
About Dr. Thomas Pope, MD
Dr. Thomas Pope, MD is a Pediatrics healthcare provider based in Smithfield, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1689655565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Pope, MD has received a total of $7,806 in payments from pharmaceutical and medical device companies, with $1,097 received in 2024. These payments were reported across 519 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($7,686).
As a Medicare-enrolled provider, Pope has provided services to 11,075 Medicare beneficiaries, totaling 15,041 services with total Medicare billing of $689,814. Data is available for 4 years (2020–2023), covering 93 distinct procedure/service records.
Practice Information
- Specialty Pediatrics
- Location Smithfield, VA
- Active Since 11/08/2005
- Last Updated 08/08/2012
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1689655565
Products in Payments
- FARXIGA (Drug) $847.91
- Ozempic (Drug) $637.80
- XIFAXAN (Drug) $417.49
- JANUVIA (Drug) $404.94
- Wegovy (Drug) $326.74
- XARELTO (Drug) $317.54
- Saxenda (Drug) $277.76
- JARDIANCE (Drug) $238.18
- VRAYLAR (Drug) $226.24
- Rybelsus (Drug) $223.27
- TRULICITY (Drug) $215.06
- INVOKANA (Drug) $196.17
- UBRELVY (Drug) $187.95
- VYVANSE (Drug) $150.96
- NURTEC ODT (Drug) $135.03
- TOUJEO (Drug) $129.32
- Livalo (Drug) $114.03
- Victoza (Drug) $91.29
- Azstarys (Drug) $87.61
- MOUNJARO (Drug) $86.56
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatrics Doctors in Smithfield
Kimberly Fox, M.d, M.D
Pediatrics — Payments: $1,541
Sandra Baucom, Md, MD
Pediatrics — Payments: $909.17
Dr. Lisa Parker, Md, MD
Pediatrics — Payments: $848.83
Ashleigh Martin, Cpnp-Pc, CPNP-PC
Pediatrics — Payments: $455.27
Siobhan Brennan, Pnp, PNP
Pediatrics — Payments: $307.45
Dr. Sally Carpenter, M.d, M.D
Pediatrics — Payments: $244.92